New Psoriasis Treatments Cost More Than A House
In the same article, home UVB phototherapy, a newer form of an established treatment, is shown to cost only $7,000 over the same 30 year time period with an equally effective profile yet with decades of safe use. With these compelling economics, the article urges Managed Care Organizations (MCO) and other Health Insurers to modify their benefit structures to encourage home phototherapy as the first treatment option for severe psoriasis. The article's author, Tom Morrow M.D. questions the rationale for MCO's paying for Biologics (Enbrel, Amevive, Raptiva, Remicade, Humira) and the equivalent of a house payment for these patients, while making it difficult for members to obtain a safe, effective, economical and physician controlled treatment that can be done in the patient's home in the form of home UV-B treatments.
National Biological Corporation http://www.natbiocorp.com, established in 1967 and the innovator of home UV phototherapy, is the world's largest manufacturer of clinical and physician-controlled home phototherapy equipment for the treatment of skin disease including severe psoriasis. National Biological's products are built to ISO-13485:2003 international quality standards and are listed with the Food and Drug Administration.
National Biological Corporation
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Smith, James. "New Psoriasis Treatments Cost More Than A House." Medical News Today. MediLexicon, Intl., 24 Sep. 2006. Web.
23 May. 2017. <http://www.medicalnewstoday.com/releases/52543.php>
Smith, J. (2006, September 24). "New Psoriasis Treatments Cost More Than A House." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.